Anemia, chronic renal disease and congestive heart failure - The cardio renal anemia syndrome: The need for cooperation between cardiologists and nephrologists

International Urology and Nephrology

Volumn 38, Issue 2, 2006, Pages 295-310

  Silverberg, Donald S ^a   Wexler, Dov ^a   Iaina, Adrian ^a   Steinbruch, Shoshana ^a   Wollman, Y ^a   Schwartz, Doron ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Anemia; Erythropoietin; Heart failure; Iron; Renal failure

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ERYTHROPOIETIN; IRON; METOPROLOL; SPIRONOLACTONE;

ACUTE HEART INFARCTION; ANEMIA; ANTIOXIDANT ACTIVITY; APOPTOSIS; BONE MARROW; CARDIOLOGIST; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; COOPERATION; CYTOKINE PRODUCTION; DIALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REGIMEN; EARLY DIAGNOSIS; ENDOTHELIUM CELL; GASTROINTESTINAL ABSORPTION; HEART MUSCLE CELL; HEART PROTECTION; HOSPITALIZATION; HUMAN; IRON ABSORPTION; IRON DEFICIENCY; IRON STORAGE; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MORTALITY; NEPHROLOGIST; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PROFESSIONAL PRACTICE; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; UREMIA;

ANEMIA; CARDIOLOGY; CHRONIC DISEASE; ERYTHROPOIETIN; HEART FAILURE; HEART FAILURE, CONGESTIVE; HUMANS; INTERDISCIPLINARY COMMUNICATION; IRON; KIDNEY DISEASES; NEPHROLOGY; SYNDROME;

EID: 33746526038     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-006-0064-8     Document Type: Review

References (148)

1. DS Silverberg D Wexler M Blum A Iaina 2003 The cardio renal anemia syndrome: Correcting anemia in patients with resistant congestive heart failure can improve both cardiac and renal function and reduces hospitalization Clin Nephrol 60 Suppl 1 S93-S102 12940539
2. DS Silverberg D Wexler M Blum D Schwartz Y Wollman A Iaina 2003 Erythropoietin should be part of congestive heart failure management Kidney Int 64 Suppl 87 S40-S47
3. DS Silverberg D Wexler M Blum et al. 2004 The interaction between heart failure, renal failure and anemia-the cardio-renal anemia syndrome Blood Purif 22 277-284 15166489
4. DS Silverberg D Wexler A Iaina 2004 The role of anemia in the progression of Congestive Heart Failure. Is there a place for erythropoietin and intravenous iron? J Nephrol 17 749-761 15593047 1:CAS:528:DC%2BD2MXht1yqs7Y%3D
5. LG Bongartz MJ Cramer PA Doevendans JA Joles B Braam 2005 The severe cardiorenal syndrome: 'Guyton revisited' Eur Heart J 26 11-17 15615794
6. GS Bleumink AM Knetsch MCJM Stirkenboom et al. 2004 Quantifying the heart failure epidemic: Prevalence, incidence rate, lifetime risk and prognosis of heart failure Eur Heart J 25 1614-1619 15351160
7. LW Miller ED Missov 2001 Epidemiology of heart failure Cardiol Clin 19 547-555 11715176 1:STN:280:DC%2BD3MnntVWktw%3D%3D
8. Task Force for the Diagnosis, Treatment of Chronic Heart Failure 2001 European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure Eur Heart J 22 1527-1560
9. JJV McMurray S Stewart 2002 The burden of heart failure Eur Heart J 4 Suppl D D50-D58
10. D Levy S Kenchaiah MG Larson et al. 2002 Long term trends in the incidence of and survival with heart failure New Engl J Med 347 1397-1402 12409541
11. NF Murphy CR Simpson FA McAlister et al. 2004 National survey of the prevalence, incidence, primary care burden and treatment of heart failure in Scotland Heart 90 1129-1136 15367505 1:STN:280:DC%2BD2cvlvV2rug%3D%3D
12. WM McClellan RD Lagston R Presley 2004 Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease J Am Soc Nephrol 15 1912-1919 15213281
13. RJ Cody S Ljungman AB Covit et al. 1988 Regulation of glomerular filtration in Chronic Congestive Heart Failure Kidney Int 34 361-367 3172644 1:STN:280:BiaD3M3nsFQ%3D
14. DS Silverberg D Wexler M Blum et al. 2000 The use of subcutaneous Erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function, functional cardiac class, and markedly reduces hospitalizations J Am Coll Cardiol 35 1737-1744 10841219 1:CAS:528:DC%2BD3cXktlGlt7Y%3D
15. D Wexler DS Silverberg D Sheps et al. 2004 Prevalence of anemia in patients admitted to hospital with a primary diagnosis of congestive heart failure Int J Cardiol 96 79-87 15203265
16. DS Silverberg D Wexler D Sheps et al. 2001 The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: A randomized controlled study J Am Coll Cardiol 37 1775-1780 11401110 1:CAS:528:DC%2BD3MXltVGhsL8%3D
17. DS Silverberg D Wexler M Blum et al. 2001 Aggressive therapy of Congestive Heart Failure and associated chronic renal failure with medications and correction of anemia stops or slows the progression of both diseases Perit Dial Int 21 Suppl 3 S236-S240 11887828
18. DS Silverberg D Wexler M Blum et al. 2003 The effect of correction of anemia in diabetic and non diabetics with severe resistant congestive heart failure and chronic renal failure by subcutanous erythropoietin and intravenous iron Nephrol Dial Transplant 18 141-146 12480972 1:CAS:528:DC%2BD38XpsFOntbk%3D
19. DS Silverberg D Wexler M Blum et al. 2005 Effects of treatment with EPO beta on outcomes in patients with anaemia and chronic renal failure Kidney Blood Press Res 28 41-47 15489560 1:CAS:528:DC%2BD2MXkslSm
20. Comin-Colet J, Bruguera J, Garcia C, et al. (2005) Effect on hospitalization and functional status of correction of mild anemia with subcutaneous erythropoietin and intravenous iron in patients with severe advanced chronic heart failure and mild renal dysfunction. Heart Failure meeting of the European Society of Cardiology, Lisbon June 2005, Abstract
21. DM Mancini SD Katz C Lang et al. 2003 Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure Circulation 107 294-299 12538431 1:CAS:528:DC%2BD3sXjt1Cgug%3D%3D
22. Novak B, Sumodi V, Bynane M, Fagnilli K, Hanna MA, Hixson E (2003) Anemia management in an outpatient heart failure center. J Cardiac Failure 9(Suppl 1):ABstract 386
23. RM Delgado R Radovancevic CC Rossem van A Bracey R Radovancevic 2004 Effect of administration of recombinant human erythropoietin in heart failure patients Eur Heart J 25 Suppl 1 386A
24. M Jones B Schenkel J Just 2005 Epoetin alpha's effect on left ventricular hypertrophy and subsequent mortality Int J Cardiol 100 253-265 15823633
25. IS Anand Y Chandrashekhar R Ferrari PA Poole-Wilson PC Harris 1993 Pathogenesis of edema in chronic anemia: Studies of body water and sodium, renal function, haemodynamics and plasma hormones Brit Heart J 70 357-362 8217445 1:STN:280:ByuD3s7jvVc%3D
26. E Sandgren AM Murray CA Herzog et al. 2005 Anemia and new-onset Congestive Heart Failure in the general Medicare population J Card Failure 11 99-105
27. DB Johnson LJ Dell'Italia 1996 Cardiac hypertrophy and failure in hypertension Curr Opin Nephrol Hypertens 5 186-191 8744544 1:STN:280:BymA3czitFU%3D
28. AM Katz 1994 The cardiomyopathy of overload: An unnatural growth response in the hypertrophied heart Ann Intern Med 121 363-371 8042826 1:CAS:528:DyaK2cXmslOlt74%3D
29. A Aessopos S Deftereos D Farmakis et al. 2004 Cardiovascular adaptation to chronic anemia in the elderly. Echocardiographic study Clin Invest Med 27 265-273 15559863
30. BC Astor DK Arnett A Brown J Coresh 2004 Association of kidney function with left ventricular morphology among African Americans: The Atherosclerotic Risk in Communities (ARIC) Study Am J Kidney Dis 43 836-845 15112174
31. MG Amin H Tigiouart DE Weiner et al. 2004 Hematocrit and left ventricular mass: The Framingham Study J Am Coll Cardiol 43 1276-1282 15063442
32. H Schunkert HW Hense 2001 A heart price to pay for anemia Nephrol Dial Transplant 16 445-448 11239013 1:STN:280:DC%2BD3MvgvVOmsg%3D%3D
33. G Olivetti C Lagrasta F Quaini et al. 1989 Capillary growth in anaemia induced ventricular remodelling in the rat heart Circ Res 65 1182-1192 2529998 1:STN:280:By%2BD3s%2FnsVA%3D
34. G Olivetti F Quaini C Lagrasta et al. 1992 Myocyte cellular hypertophy and hyperplasia contribute to ventricular wall modelling in anemia induced cardiac hypertrophy in rats Am J Pathol 141 227-239 1385927 1:STN:280:By2A3sjgslc%3D
35. MA Rossi SV Carillo 1983 Electron microscopic study on the cardiac hypertrophy induced by iron deficiency in the rat Br J Exp Pathol 64 373-387 6225450 1:CAS:528:DyaL3sXlslCmurY%3D
36. K Rakusan N Cicutti F Kolar 2001 Effect of anemia on cardiac function, microvascular structure and capillary hematocrit in rat hearts Am J Physiol Heart Circ Physiol 280 H1407-H1414 11179091 1:CAS:528:DC%2BD3MXjtV2ntrg%3D
37. LE Davis AR Hohimer 1991 Hemodynamics and organ flow in fetal sheep subjected to chronic anemia Am J Physiol 261 R152-R158
38. LE Davis R Hohimer RA Brace 1996 Changes in left thoracic lymph flow during progressive anemia in the ovine fetus Am J Obstet Gynecol 174 1469-1476 9065113 1:STN:280:BymB2c%2FgslE%3D
39. AS Androne SD Katz L Lund et al. 2003 Hemodilution is common in patients with advanced heart failure Circulation 107 226-229 12538419
40. BP Shapiro HH Chen JC Burnett MM Redfield 2003 Use of plasma Brain Natriuretic peptide concentration to aid in the diagnosis of heart failure Mayo Clin Proc 78 481-486 12683700 1:CAS:528:DC%2BD3sXjtVylu7k%3D
41. S Brucks WC Little T Chao et al. 2004 Relation of anemia to diastolic heart failure and the effect on outcome Am J Cardiol 93 1055-1057 15081458
42. Uber PA, Park MH, Scott RL, Mehra MR (2003) B-Type Natriuretic peptide levels are closely associated with anemia in chronic heart failure independent of underlying renal function. J Cardiac Failure 9(Suppl 1):133A Abstract
43. P Meer Van der AA Voors E Lipsic TDJ Smilde WH Gilst van DJ Veldhuisen van 2004 Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure J Am Coll Cardiol 44 63-67 15234408
44. H Tsuji N Nishino Y Kimura et al. 2004 Haemoglobin level influences plasma brain natriuretic peptide concentration Acta Cardiol 59 527-531 15529559
45. Knudsen CW, Vik-Mo H, Omland T (2005) Blood hemoglobin is an independent predictor of B-type natriuretic peptide levels. Clin Sci Mar 8
46. H Kanka Y Kita T Okamura et al. 2005 What factors are associated with high B-type natriuretic peptide levels in a general Japanese population? J Hum Hypertens 19 165-172
47. M Kikuchi T Inagaki 1999 Atrial Natriuretic Peptide in aged patients with iron deficiency anemia Arch Gerontol Geriatr 28 105-115 15374090 1:CAS:528:DyaK1MXhs1OmtrY%3D
48. DC Holland M Lam 2000 Predictors of hospitalization and death among pre-dialysis patients: A retrospective study Nephrol Dial Transplant 15 650-658 10809806 1:STN:280:DC%2BD3c3ntVenuw%3D%3D
49. SS Khan WH Kazmi R Abichandani H Tighiouart BJ Pereira AT Kausz 2002 Health care utilization among patients with chronic kidney disease Kidney Int 62 229-236 12081582
50. St Peter WL, Xue J, Ebben J, Collins A (2001) Pre-end stage renal disease erythropoietin use predicts hospitalization in the periods before and after end-stage renal disease diagnosis. J Am Soc Nephrol 12(Suppl):ABstract 1274
51. AJ Collins 2003 Anaemia management prior to dialysis: Cardiovascular benefits and cost-benefit observations Nephrol Dial Transplant 18 Suppl 2 ii2-ii6 12819293
52. F Valderabano W Horl IC Macdougall J Rossert B Rutkowski J-P Wauters 2003 PRE-dialysis survey on anemia management Nephrol Dial Transplant 18 89-100
53. JC Fink SA Blahut M Reddy PD Light 2001 Use of erythropoietin before the initiation of dialysis and its impact on mortality Am J Kidney Dis 37 348-355 11157377 1:CAS:528:DC%2BD3MXhtF2itbk%3D
54. JL Xue WL St. Peter JP Ebben SE Everson AJ Collins 2002 Anemia treatment in the Pre-ESRD period and associated mortality in elderly patients Am J Kidney Dis 40 1153-1161 12460033
55. GFM Strippoli JC Craig C Manno FP Schena 2004 Hemoglobin targets for the anemia of chronic kidney disease: A meta-analysis of randomized, controlled studies J Am Soc Nephrol 15 3154-3165 15579519
56. RL Perlman FO Finkelstein L Liu et al. 2005 Quality of life in chronic kidney disease (CKD): A cross sectional analysis in the Renal Research Institute-CKD study Am J Kidney Dis 45 658-666 15806468
57. CA Herzog HA Muster S Li AJ Collins 2004 Impact of Congestive Heart Failure, Chronic Kidney Disease and Anemia on survival in the medicare population J Cardiac Failure 10 467-472
58. P Muntner J He BC Astor AR Folsom J Coresh 2005 Traditional and non traditional risk factors predict coronary heart disease: Results from the Atherosclerotic Risk in Communities Study J Am Soc Nephrol 16 529-538 15625072
59. CT Jurkovitz JL Abramson LV Vaccarino et al. 2003 Association of high serum creatinine ans anemia increases the risk of coronary events: results from the prospective community-based atherosclerosis risk in communities (ARIC) study J Am Soc Nephrol 14 2919-2925 14569102 1:CAS:528:DC%2BD3sXotFWntrw%3D
60. JL Abramson CT Jurkovitz LV Vaccarino et al. 2003 Chronic kidney disease, anemia and incident stroke in a middle-aged, community based population: The ARIC Study Kidney Int 64 610-615 12846757
61. NS Anevekar JJV McMurray EJ Velzquez et al. 2004 Relation between renal dysfunction and cardiovascular outcomes after a myocardial infarction N Engl J Med 351 1285-1295
62. AS Go GM Chertow D Fan CE McCulloch Hsu C-y 2004 Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 1296-1305 15385656 1:CAS:528:DC%2BD2cXnvFSgtr8%3D
63. RN Foley AM Murray S Li et al. 2005 Chronic kidney disease and the risk for cardilvascular disease, renal replacement and death in the United States Medicare population1998-1999 J Am Soc Nephrol 16 489-495 15590763
64. Bolger AP, Doehner W, Sharma R, Coate JS, Anker S (2002) Anemia in chronic heart failure: The relationship to inflammatory cytokine production and prognostic importance. Circulation 106(Suppl):2819A, Abstract
65. T Grune O Sommerburg WG Siems 2000 Oxidative stress in anemia Clin Nephrol 53 suppl 1 S18-S22 10746801 1:CAS:528:DC%2BD3MXhsVCrsL4%3D
66. K Ludat O Sommerburg T Grune WG Siems E Riedel H Hampl 2000 Oxidation parameters in complete correction of renal anemia Clin Nephrol 53 suppl 1 S30-S35 10746803 1:CAS:528:DC%2BD3MXhsVCrsLw%3D
67. K Amann C Ritz M Adamczak E Ritz 2003 Why is coronary heart disease of uraemic patients so frequent and so devastating? Nephrol Dial Transplant 18 631-640 12637626
68. K Tyralla K Amann 2003 Morphology of the heart and arteries in renal failure Kidney Int 84 Suppl 84 S80-S83
69. I Anand JJ McMurray Whitmore et al. 2004 Anemia and its relationship to clinical outcome in heart failure Circulation 110 149-154 15210591
70. M Kosiborod GL Smith MJ Radford JM Foody HM Krumholz 2003 The prognostic importance of anemia in patients with heart failure Am J Med 114 112-119 12586230
71. Golden JS, Fallick CC, Josephson SR et al. (2002) Baseline hematocrit predicts clinical outcomes in heart failure. Circulation 106(Suppl):3358A, Abstract
72. RJ Nordyke JJ Kim GA Goldberg et al. 2004 Impact of anemia on hospitalization time, charges and mortality in patients with heart failure Value Health 7 464-471 15449638
73. GM Felker WA Gattis JD Leimberger et al. 2003 Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure Am J Cardiol 92 625-628 12943893
74. DD Gregory MJ Sarnak MA Konstam B Pereira D Salem 2003 Impact of chronic kidney disease and anemia on hospitalization expense in patients with left ventricular dysfunction Am J Cardiol 92 1300-1305 14636907
75. DE Forman J Butler Y Wang et al. 2004 Incidence, predictors of admission, and impact of worsening renal function among patients hospitalized with heart failure J Am Coll Cardiol 43 61-67 14715185
76. J Butler DE Forman WT Abraham et al. 2004 Relationship between heart failure treatment and development of worsening renal function among hospitalized patients Am Heart J 147 331-338 14760333
77. A Levin 2002 The relationship of hemoglobin level and survival: Direct or indirect effects Nephrol Dial Transplant 17 Suppl 5 8-13 12091600 1:CAS:528:DC%2BD38XmsFagtbY%3D
78. WF Keane BM Brenner D Zeeuw de et al. 2003 The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL Study Kidney Int 63 1499-1500 12631367
79. C Gouva P Nikolopoulos JPA Ioannidis KC Siamopoulos 2004 Treating anemia early in renal failure slows the decline of renal function: A randomized controlled study Kidney Int 66 753-760 15253730
80. E Nikolsky R Mehran Z Lasic et al. 2005 Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary intervention Kidney Int 67 706-713 15673320
81. JA Wahr 1998 Myocardial ischemia in anaemic patients Br J Anaesth 81 Suppl S10-S15
82. Hebert PC (2004) Physiological aspects of anemia. Crit Care Clin 20:187-212
83. Das SR, Dries DL, Drazner MH, Yancy CW, Chae CU (2004) Low hematocrit is associated with risk of progression from ALVD to symptomatic heart failure. Circulation 17(Suppl II):3474, Abstract
84. Weiner DE, Tighiouart H, Vlagopoulos PT et al. (2005) Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. J Am Soc Nephrol Apr 13
85. W-C Wu SS Rathore Y Wang MJ Radford H Krumholtz 2001 Blood transfusion in elderly patients with acute myocardial infarction N Engl J Med 345 1230-1236 11680442 1:STN:280:DC%2BD3Mrnt1Gksw%3D%3D
86. PC Lee AS Kini C Ahsan E Fisher SK Sharma 2004 Anemia is an independent predictor of mortality after percutaneous coronary intervention J Am Coll Cardiol 44 541-546 15358017
87. E Nikolsky ED Aymong A Halkin et al. 2004 Impact of anemia in patients with acute myocardial infarction undergoing percutaneous coronary intervention J Am Coll Cardiol 44 547-553 15358018
88. MS Sabatine DA Morrow RP Giugliano et al. 2005 Association of hemoglobin levels with clinical outcomes in Acute Coronary Syndromes Circulation 111 2042-2049 15824203 1:CAS:528:DC%2BD2MXjtlKlt78%3D
89. E Lipsic IC Horst van der AA Voors et al. 2005 Hemoglobin levels and 30 day mortality in patients with myocardial infarction Int J Cardiol 100 289-292 15823637
90. RD Langston R Presley WD Flanders WM McClellan 2003 Renal Insufficiency and anemia are independent risk factors for death among patients with acute myocardial infarction Kidney Int 64 1398-1405 12969159
91. H Reinecke T Trey J Wellmann et al. 2003 Hemoglobin-related mortality in patients undergoing percutaneous coronary interventions Eur Heart J 24 2142-2150 14643275 1:CAS:528:DC%2BD3sXptF2qsbs%3D Hemoglobin-related mortality in patients undergoing percutaneous coronary interventions Eur Heart J 24 2142-2150 14643275 1:CAS:528:DC%2BD3sXptF2qsbs%3D
92. CB Arant TR Wessel MB Olson et al. 2004 Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain J Am Coll Cardiol 43 2009-2014 15172405 1:CAS:528:DC%2BD2cXksVCjt7c%3D
93. HS Gurm AM Lincoff NS Kleiman et al. 2004 Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions Am J Cardiol 94 30-34 15219504
94. RS McKechnie D Smith C Montoye et al. 2004 Prognostic implications of anemia on in-hospital outcomes after percutaneous coronary interventions Circulation 110 271-277 15226214
95. Y Vanrenterghem 2004 Anaemia after renal transplantation Nephrol Dial Transplant 19 Suppl 5 V54-V58 15284361
96. C Rigatto P Parfrey R Foley C Negrijn C Tribula J Jeffrey 2002 Congestive Heart Failure in renal transplant recipients: Risk Factors, outcomes and relationship with ischemic heart disease J Am Soc Nephrol 13 1084-1090 11912270
97. C Rigatto R Foley J Jeffrey C Negrijn C Tribula P Parfrey 2003 Electrocardiographic left ventricular hypertrophy in renal transplant recipients: Prognostic value and impact of blood pressure and anemia J Am Soc Nephrol 14 462-468 12538748
98. A Djamali YT Becker WD Simmons CA Johnson N Premasathian BN Becker 2003 Increasing hematocrit reduces early posttransplant cardiovascular risk in diabetic transplant recipients Transplantation 76 816-820 14501860
99. PO Iverson PR Woldbaek T Tonnessen G Christensen 2002 Decreased hematopoiesis in bone marrow of mice with congestive heart failure Am J Physiol Regul Integr Comp Physiol 282 R166-R172
100. EH Herrera-Garza SJ Stetson A Cubillos-Garzon MT Vooltich JA Farmer G Torre-Amione 1999 Tumor necrosis factor: A mediator of disease progression in the failing human heart Chest 115 1170-1174 10208224 1:STN:280:DyaK1M3it12jtw%3D%3D
101. RT Means 1999 Advances in the anemia of chronic disease Int J Hematol 70 7-12 10446488
102. RT Means 2004 Hepcidin and anaemia Blood Rev 18 219-225 15501550
103. R Deicher WH Horl 2004 Hepcidin: A molecular link between inflammation and anaemia Nephrol Dial Transplant 19 521-524 14767000 1:CAS:528:DC%2BD2cXhtVKrt7Y%3D
104. S Rivera L Liu E Nemeth V Gabayan OE Sorensen T Ganz 2005 Hepcidin excess induces the sequestration of iron and exacerbates tumor-associated anemia Blood 105 1797-1802 15479721 1:CAS:528:DC%2BD2MXhsVGjsbw%3D
105. Detivaud L, Nemeth E, Boudjema K et al. (2005) Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels and hepatic function. Blood Mar 29
106. ND Vaziri 2001 Erythropoietin and transferrin metabolism in nephrotic syndrome Am J Kidney Dis 38 1-8 11431174 1:CAS:528:DC%2BD3MXlsVOlsrY%3D
107. IC Macdougall 1999 The role of ACE inhibitors and angiotensin II receptor blockers in the response to erythropoietin Nephrol Dial Transplant 14 1836-1841 10462256 1:STN:280:DyaK1MzovFemsA%3D%3D
108. A Ishani E Weinhandl Z Zhao et al. 2005 Angiotensin-Converting Enzyme Inhibitor as a risk factor for the development of anemia and the impact of incident anemia on mortality in patients with left ventricular dysfunction J Am Coll Cardiol 45 391-399 15680718 1:CAS:528:DC%2BD2MXoslChtQ%3D%3D
109. AR Odabas R Cetinkaya Y Selcuk S Keles H Bilen 2003 The effect of high dose Losartan on erythropoietin resistance in patients undergoing hemodialysis Panminerva Med 45 59-62 12682621 1:STN:280:DC%2BD3s7msFWltg%3D%3D
110. MP Kooistra EC Niemantverdriet A Es van et al. 1998 Iron absorption in erythropoietin-treated haemodialysis patients: Effects of iron availability, inflammation and aluminium Nephrol Dial Transplant 13 82-88 9481720 1:CAS:528:DyaK1cXoslGmuw%3D%3D
111. MC Thomas RJ MacIsaac C Tslalmandris D Power G Jerums 2003 Unrecognized anemia in patients with diabetes Diabetes Care 26 1164-1169 12663591
112. MC Thomas ME Cooper C Tsalamandris R MacIsaac G Jerums 2005 Anemia with impaired Erythropoietin response in diabetic patients Arch Int Med 165 466-469
113. MC Thomas RJ MacIsaac C Tsalamandris 2004 Anemia in patients with type 1 diabetes J Clin Endocrinol Metab 89 4359-4363 15356033 1:CAS:528:DC%2BD2cXnslWhtr4%3D
114. TM El-Achkar SE Ohmit PA McCullough et al. 2005 Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: The Kidney Early Evaluation Program Kidney Int 67 1483-1488 15780101
115. C-Y Hsu CE McCullough GC Curhan 2002 Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey J Am Soc Nephrol 13 504-410 11805181
116. C-Y Hsu CE McCullough GC Curhan 2002 Iron status and hemoglobin level in Chronic Renal Failure J Am Soc Nephrol 13 2783-2786 12397050 1:CAS:528:DC%2BD38XnvF2lsL4%3D
117. DS Silverberg M Blum Z Agbaria et al. 1999 Intravenous iron for the treatment of predialysis anemia Kidney Int 55 Suppl 67 S79-S85
118. DS Silverberg M Blum Z Agbaria et al. 2001 The effect of IV iron alone or in combination with low dose Erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period Clin Nephrol 55 212-219 11316241 1:CAS:528:DC%2BD3MXpt1Khu7s%3D
119. C Charytan W Qunibi GR Bailie 2005 Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with Chronic Kidney Disease not on dialysis Nephron Clin Pract 100 c55-c62 15824508 1:CAS:528:DC%2BD2MXltlWrt7c%3D
120. WHW Tang H Miller M Partin et al. 2003 Anemia in ambulatory patients with chronic heart failure: A single-center clinical experience derived from electronic medical records J Am Coll Cardiol 41 Suppl A 157A
121. JA Ezekowitz FA McAlister PW Armstrong 2003 Anemia is common in heart failure and is associated with poor outcomes: Insights from a cohort of 12065 patients with new onset heart failure Circulation 107 223-225 12538418
122. JA Ezekowitz FA McAlister PW Armstrong 2005 The interaction among sex, hemoglobin and outcomes in a specialty heart failure clinic Can J Cardiol 21 165-171 15729416
123. M Packer JN Cohn et al. 1999 Consensus recommendations for the management of chronic heart failure Am J Cardiol 83 1A-38A
124. SA Hunt DW Baker MC Chin et al. 2001 ACC/AHA guidelines for the evaluation and management of chronic heart failure: Executive Summary J Am Coll Cardiol 38 2101-2113 11738322 1:STN:280:DC%2BD3MnptVegtg%3D%3D
125. P Meer van der AA Voors E Lipsic WH Gilst van DJ Veldhuisen van 2004 Erythropoietin in cardiovascular diseases Eur Heart J 13 285-291
126. KJ Smith AJ Bleyer WC Little DC Sane 2003 The cardiovascular effects of erythropoietin Cardiovasc Res 59 538-548 14499855 1:CAS:528:DC%2BD3sXnt1Glt78%3D
127. K Maiese F Li ZZ Chong 2005 New avenues of exploration for erythropoietin JAMA 293 90-95 15632341 1:CAS:528:DC%2BD2MXht1Gmtw%3D%3D
128. B Kristal R Shurtz-Swirski SM Sasha et al. 1999 Interaction between interaction between erythropoietin and peripheral polymorhonuclear leucocytes in hemodialysis patients Nephron 81 406-413 10095176 1:CAS:528:DyaK1MXitlKltro%3D
129. Bailie GR, Eisele G, Liu L, et al. (2005) Patterns of medication use in RRI-CKD study: Focus on medications with cardiovascular effects. Nephrol Dial Transplant Mar 15
130. J Ezekowitz FA McAlister KH Humphries et al. 2004 The association among renal insufficiency, pharmacotherapy and outcomes in 6427 patients with heart failure and coronary heart disease J Am Coll Cardiol 44 1587-1592 15489090
131. JFE Mann HC Gerstein I Dulau-Florea E Lonn 2003 Cardiovascular risk in patients with mild renal insufficiency Kidney Int 63 Suppl 84 S192-S196
132. MG Shlipak WS Browner H Noguchi et al. 2001 Comparison of the effects of angiotensin converting enzyme inhibitors and beta blockers on survival in elderly patients with reduced left ventricular function after myocardial infarction Am J Cardiol 110 425-433 1:CAS:528:DC%2BD3MXivFegsbo%3D
133. E Erdmann P Lechat P Verkenne et al. 2001 Results from post-hoc analyses of the CIBIS II trial: Effect of bisoprolol on high-risk patient groups with chronic heart failure Eur J Heart Failure 3 469-479 1:CAS:528:DC%2BD3MXntVSgt7c%3D
134. G Wolf E Ritz 2005 Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: Pathophysiology and indications Kidney Int 67 799-812 15698420 1:CAS:528:DC%2BD2MXis1Grtrc%3D
135. B Young ME Dunlap MA Pfeffer et al. 2004 Mortality and morbidity reduction with Candesartan in patients with Chronic Heart Failure and left ventricular systolic dysfunction: Results of the CHARM low-left ventricular ejection fraction trials Circulation 110 2618-2626 15492298 1:CAS:528:DC%2BD2cXos1Ght74%3D
136. G Cice L Ferrara A D'Andrea et al. 2003 Carvedilol increases two year survival in dialysis patients with dilated cardiomyopathy J Am Coll Cardiol 41 448-444
137. A Al-Ahmad WM Rand G Manjunath et al. 2001 Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction J Am Coll Cardiol 8 955-962
138. WM McClellan WD Flanders RD Langston et al. 2002 Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: A population-based study J Am Soc Nephrol 13 1928-1936 12089390
139. M Tonelli L Moye FM Sacks et al. 2003 Cholesterol and Recurrent Events (CARE) Trial Investigators. Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency Ann Int Med 138 98-104 12529091 1:CAS:528:DC%2BD3sXitVWksrk%3D
140. R Collins J Armitage S Parish et al. 2003 MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 5693 people with diabetes: A randomized placebo-controlled trial Lancet 36 2005-2116
141. K Node M Fujita M Kitakaze M Hori JK Liao 2003 Short-term statin therapy improves cardiac function and symptoms in patients with dilated cardiomyopathy Circulation 108 839-843 12885745 1:CAS:528:DC%2BD3sXmtFCisbc%3D
142. TB Horwich WR MacLellan GC Fonarow 2004 Statin therapy is associated with improved survival in ischemic and non-ishemic heart failure J Am Coll Cardiol 43 642-648 14975476 1:CAS:528:DC%2BD2cXitlaqsbc%3D
143. C Wanner V Krane W Marz et al. 2004 Randomized controlled trial on the efficacy and safety of atorvaststin in patients with type 2 diabetes on hemodialysis (4D Study): Demographic and baseline characteristics Kidney Blood Press Res 27 259-266 15316128 1:CAS:528:DC%2BD2cXntlWms7w%3D
144. Wanner C, Ritz E et al. (2004) Presented at the Am Soc Nephrol meeting. St Louis, Nov 2004
145. H Hampl L Hennig C Rosenberger et al. 2005 Effects of optimized heart failure therapy and anemia correction with epoetin β on left ventricular mass in hemodialysis patients Am J Nephrol 25 211-220 15900093 1:CAS:528:DC%2BD2MXmtVSnt7c%3D
146. A Besarab WK Bolton JK Browne et al. 1998 The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin N Engl J Med 339 584-590 9718377 1:CAS:528:DyaK1cXlvVyrtr8%3D
147. Parfrey PS, Foley RN, Wittreich BH, Sullivan DJ, Zagari MJ, Frei D (2005) Double-blind comparison of full and partial correction in incident hemodialysis patients without symptomatic heart disease. J Am Soc Nephrol (in publication)
148. SD Roger LP McMahon A Clarkson 2004 Effects of early and late intervention Epoetin α on left ventricular mass among patients with chronic kidney disease (stages 3 and 4): Results of a randomized clinical trial J Am Soc Nephrol 15 148-156 14694167 1:CAS:528:DC%2BD2cXhs1aitQ%3D%3D